Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC16271;272;273 chr2:178804597;178804596;178804595chr2:179669324;179669323;179669322
N2AB16271;272;273 chr2:178804597;178804596;178804595chr2:179669324;179669323;179669322
N2A16271;272;273 chr2:178804597;178804596;178804595chr2:179669324;179669323;179669322
N2B16271;272;273 chr2:178804597;178804596;178804595chr2:179669324;179669323;179669322
Novex-116271;272;273 chr2:178804597;178804596;178804595chr2:179669324;179669323;179669322
Novex-216271;272;273 chr2:178804597;178804596;178804595chr2:179669324;179669323;179669322
Novex-316271;272;273 chr2:178804597;178804596;178804595chr2:179669324;179669323;179669322

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTG
  • RefSeq wild type template codon: CAC
  • Domain: Ig-1
  • Domain position: 11
  • Structural Position: 14
  • Q(SASA): 0.4684
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/M rs756212082 -0.29 1.0 N 0.631 0.334 None gnomAD-2.1.1 2.12E-05 None None None 0.059(TCAP) N None 0 0 None 0 0 None 3.27E-05 None 0 3.1E-05 1.38696E-04
V/M rs756212082 -0.29 1.0 N 0.631 0.334 None gnomAD-3.1.2 1.97E-05 None None None 0.059(TCAP) N None 0 0 0 0 0 None 0 0 4.41E-05 0 0
V/M rs756212082 -0.29 1.0 N 0.631 0.334 None gnomAD-4.0.0 2.04472E-05 None None None 0.059(TCAP) N None 0 0 None 0 0 None 0 0 2.54245E-05 1.09818E-05 3.20154E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.1846 likely_benign 0.1755 benign -0.705 Destabilizing 0.999 D 0.51 neutral N 0.487130459 None -0.176(TCAP) N
V/C 0.9507 likely_pathogenic 0.9418 pathogenic -0.844 Destabilizing 1.0 D 0.61 neutral None None None 0.562(TCAP) N
V/D 0.3894 ambiguous 0.3653 ambiguous -0.436 Destabilizing 1.0 D 0.707 prob.neutral None None None 1.594(TCAP) N
V/E 0.2532 likely_benign 0.2378 benign -0.485 Destabilizing 0.999 D 0.689 prob.neutral N 0.439994076 None 1.617(TCAP) N
V/F 0.2723 likely_benign 0.247 benign -0.578 Destabilizing 1.0 D 0.681 prob.neutral None None None -0.093(TCAP) N
V/G 0.3548 ambiguous 0.338 benign -0.915 Destabilizing 1.0 D 0.687 prob.neutral D 0.558537896 None -0.188(TCAP) N
V/H 0.7203 likely_pathogenic 0.6986 pathogenic -0.299 Destabilizing 1.0 D 0.679 prob.neutral None None None -0.546(TCAP) N
V/I 0.1 likely_benign 0.097 benign -0.272 Destabilizing 0.983 D 0.463 neutral None None None -0.15(TCAP) N
V/K 0.4975 ambiguous 0.4745 ambiguous -0.733 Destabilizing 1.0 D 0.69 prob.neutral None None None -0.44(TCAP) N
V/L 0.237 likely_benign 0.2169 benign -0.272 Destabilizing 0.978 D 0.501 neutral N 0.515012245 None -0.15(TCAP) N
V/M 0.1888 likely_benign 0.1711 benign -0.488 Destabilizing 1.0 D 0.631 neutral N 0.507534993 None 0.059(TCAP) N
V/N 0.3346 likely_benign 0.3184 benign -0.628 Destabilizing 0.998 D 0.708 prob.delet. None None None 0.331(TCAP) N
V/P 0.7662 likely_pathogenic 0.7524 pathogenic -0.381 Destabilizing 0.998 D 0.694 prob.neutral None None None -0.157(TCAP) N
V/Q 0.3977 ambiguous 0.3786 ambiguous -0.781 Destabilizing 0.999 D 0.695 prob.neutral None None None 0.555(TCAP) N
V/R 0.4319 ambiguous 0.4057 ambiguous -0.228 Destabilizing 1.0 D 0.707 prob.neutral None None None -1.043(TCAP) N
V/S 0.2216 likely_benign 0.2088 benign -1.05 Destabilizing 1.0 D 0.695 prob.neutral None None None 0.077(TCAP) N
V/T 0.1517 likely_benign 0.1463 benign -0.987 Destabilizing 0.997 D 0.635 neutral None None None 0.079(TCAP) N
V/W 0.8904 likely_pathogenic 0.8633 pathogenic -0.7 Destabilizing 1.0 D 0.693 prob.neutral None None None -0.454(TCAP) N
V/Y 0.7532 likely_pathogenic 0.7246 pathogenic -0.41 Destabilizing 1.0 D 0.683 prob.neutral None None None -0.326(TCAP) N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.